New aspects of genetics and surgical management in pancreatic cancer: The Johns Hopkins experience

Research output: Contribution to journalArticle

Abstract

Pancreatic cancer remains a leading cause of cancer death in the USA. Recent progress provides hope for a better understanding of the molecular biology of pancreatic cancer. Structural chromosomal studies have identified recurrent chromosome abnormalities. Allelotype work has helped identify the loci of tumour suppressor genes (p53, DPC4, p16 and BRCA2), all of which appear to play a role in pancreatic carcinogenesis. K-ras oncogene activation has been linked to cigarette smoking, may be an early event in carcinogenesis and appears promising as a tool for early detection. Additionally, molecular genetics has enabled the accumulation of information in cases of familial pancreatic cancer, supporting the National Familial Pancreas Tumor Registry at Johns Hopkins. The recent surgical experience at Johns Hopkins is encouraging. In a cohort of 149 consecutive patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma, the postoperative in-hospital mortality rate was 0.7%. The data for 201 resected patients from 1970 to 1994 indicated a 21% actuarial five-year survival rate, with 11 five-year survivors. Multivariate analysis indicated that the factors favouring long-term survival following pancreaticoduodenectomy include a tumour diameter less than 3 cm, negative resected lymph nodes, negative resection margins and surgery in the decade of the 1990s. The use of postoperative combined modality chemoradiation therapy also favoured long-term survival.

Original languageEnglish (US)
Pages (from-to)221-228
Number of pages8
JournalAsian Journal of Surgery
Volume20
Issue number3
StatePublished - 1997

Fingerprint

Pancreatic Neoplasms
Pancreaticoduodenectomy
Molecular Biology
Hope
Carcinogenesis
Combined Modality Therapy
Neoplasms
ras Genes
Survival
Hospital Mortality
Tumor Suppressor Genes
Chromosome Aberrations
Survivors
Registries
Pancreas
Cause of Death
Adenocarcinoma
Multivariate Analysis
Survival Rate
Lymph Nodes

ASJC Scopus subject areas

  • Surgery

Cite this

@article{9d91fbd2c4484465b8ad2d898729f591,
title = "New aspects of genetics and surgical management in pancreatic cancer: The Johns Hopkins experience",
abstract = "Pancreatic cancer remains a leading cause of cancer death in the USA. Recent progress provides hope for a better understanding of the molecular biology of pancreatic cancer. Structural chromosomal studies have identified recurrent chromosome abnormalities. Allelotype work has helped identify the loci of tumour suppressor genes (p53, DPC4, p16 and BRCA2), all of which appear to play a role in pancreatic carcinogenesis. K-ras oncogene activation has been linked to cigarette smoking, may be an early event in carcinogenesis and appears promising as a tool for early detection. Additionally, molecular genetics has enabled the accumulation of information in cases of familial pancreatic cancer, supporting the National Familial Pancreas Tumor Registry at Johns Hopkins. The recent surgical experience at Johns Hopkins is encouraging. In a cohort of 149 consecutive patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma, the postoperative in-hospital mortality rate was 0.7{\%}. The data for 201 resected patients from 1970 to 1994 indicated a 21{\%} actuarial five-year survival rate, with 11 five-year survivors. Multivariate analysis indicated that the factors favouring long-term survival following pancreaticoduodenectomy include a tumour diameter less than 3 cm, negative resected lymph nodes, negative resection margins and surgery in the decade of the 1990s. The use of postoperative combined modality chemoradiation therapy also favoured long-term survival.",
author = "Yeo, {C. J.} and Kern, {Scott E} and Hruban, {Ralph H} and Cameron, {John L}",
year = "1997",
language = "English (US)",
volume = "20",
pages = "221--228",
journal = "Asian Journal of Surgery",
issn = "1015-9584",
publisher = "Elsevier Taiwan LLC",
number = "3",

}

TY - JOUR

T1 - New aspects of genetics and surgical management in pancreatic cancer

T2 - The Johns Hopkins experience

AU - Yeo, C. J.

AU - Kern, Scott E

AU - Hruban, Ralph H

AU - Cameron, John L

PY - 1997

Y1 - 1997

N2 - Pancreatic cancer remains a leading cause of cancer death in the USA. Recent progress provides hope for a better understanding of the molecular biology of pancreatic cancer. Structural chromosomal studies have identified recurrent chromosome abnormalities. Allelotype work has helped identify the loci of tumour suppressor genes (p53, DPC4, p16 and BRCA2), all of which appear to play a role in pancreatic carcinogenesis. K-ras oncogene activation has been linked to cigarette smoking, may be an early event in carcinogenesis and appears promising as a tool for early detection. Additionally, molecular genetics has enabled the accumulation of information in cases of familial pancreatic cancer, supporting the National Familial Pancreas Tumor Registry at Johns Hopkins. The recent surgical experience at Johns Hopkins is encouraging. In a cohort of 149 consecutive patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma, the postoperative in-hospital mortality rate was 0.7%. The data for 201 resected patients from 1970 to 1994 indicated a 21% actuarial five-year survival rate, with 11 five-year survivors. Multivariate analysis indicated that the factors favouring long-term survival following pancreaticoduodenectomy include a tumour diameter less than 3 cm, negative resected lymph nodes, negative resection margins and surgery in the decade of the 1990s. The use of postoperative combined modality chemoradiation therapy also favoured long-term survival.

AB - Pancreatic cancer remains a leading cause of cancer death in the USA. Recent progress provides hope for a better understanding of the molecular biology of pancreatic cancer. Structural chromosomal studies have identified recurrent chromosome abnormalities. Allelotype work has helped identify the loci of tumour suppressor genes (p53, DPC4, p16 and BRCA2), all of which appear to play a role in pancreatic carcinogenesis. K-ras oncogene activation has been linked to cigarette smoking, may be an early event in carcinogenesis and appears promising as a tool for early detection. Additionally, molecular genetics has enabled the accumulation of information in cases of familial pancreatic cancer, supporting the National Familial Pancreas Tumor Registry at Johns Hopkins. The recent surgical experience at Johns Hopkins is encouraging. In a cohort of 149 consecutive patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma, the postoperative in-hospital mortality rate was 0.7%. The data for 201 resected patients from 1970 to 1994 indicated a 21% actuarial five-year survival rate, with 11 five-year survivors. Multivariate analysis indicated that the factors favouring long-term survival following pancreaticoduodenectomy include a tumour diameter less than 3 cm, negative resected lymph nodes, negative resection margins and surgery in the decade of the 1990s. The use of postoperative combined modality chemoradiation therapy also favoured long-term survival.

UR - http://www.scopus.com/inward/record.url?scp=0030763313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030763313&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030763313

VL - 20

SP - 221

EP - 228

JO - Asian Journal of Surgery

JF - Asian Journal of Surgery

SN - 1015-9584

IS - 3

ER -